Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights

Company Performance - Hologic (HOLX) closed at $64.14, reflecting a -1.6% change from the previous day, underperforming the S&P 500's daily loss of 0.84% [1] - Over the past month, Hologic's shares have increased by 14.77%, while the Medical sector remained flat at 0% and the S&P 500 gained 1.44% [1] Earnings Expectations - Hologic is expected to report an EPS of $1.06, unchanged from the prior-year quarter, with a revenue estimate of $1.01 billion, indicating a 0.39% decrease from the same quarter last year [2] - Full-year Zacks Consensus Estimates project earnings of $4.2 per share and revenue of $4.08 billion, representing year-over-year changes of +2.94% and +1.16%, respectively [3] Analyst Estimates and Valuation - Recent changes in analyst estimates for Hologic are crucial, as positive revisions often indicate a favorable business outlook [3] - Hologic currently has a Zacks Rank of 4 (Sell), with a Forward P/E ratio of 15.52, which is a discount compared to the industry average Forward P/E of 26.88 [5] - The PEG ratio for Hologic stands at 2.39, compared to the Medical - Instruments industry average of 2.26 [6] Industry Context - The Medical - Instruments industry is ranked 151 in the Zacks Industry Rank, placing it in the bottom 39% of over 250 industries [6] - The Zacks Rank system indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]